Skip to main content

Year: 2023

Alta Copper Announces Start of Metallurgical Testwork and Provides Update on Permitting & Community

VANCOUVER, British Columbia, Nov. 02, 2023 (GLOBE NEWSWIRE) — Alta Copper Corp. (TSX: ATCU; OTCQX: ATCUF; BVL: ATCU) (“Alta Copper” or the “Company”) advises the commencement of metallurgical testwork for the Cañariaco Sur deposit to be used in the optimized Preliminary Economic Assessment (“PEA”)and progress update on drill permit application and community. Joanne C. Freeze, President and Chief Executive Officer of Alta Copper, commented: “We are very pleased that we have identified potential further benefits to the overall Cañariaco project by way of blending the Cañariaco Sur copper and gold resource with some of Cañariaco Norte mineral resources. The Cañariaco Sur deposit has a higher gold content and has no deleterious elements such that blending Sur and Norte is expected to increase gold content while reducing impurities...

Continue reading

InspireMD to Participate in Upcoming November Investor Conferences

TEL AVIV, Israel and MIAMI, Fla., Nov. 02, 2023 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for treatment of carotid artery disease and prevention of stroke, today announced that the Marvin Slosman, Chief Executive Officer, will participate in three upcoming investor conferences in November: Wolfe Research Healthcare Conference Wednesday, November 15, 2023 Fireside chat: 12:30pm ET Canaccord Genuity MedTech, Diagnostics, Digital Health & Services Forum Thursday, November 16, 2023 Investor one-on-one meetings only Piper 35th Annual Healthcare Conference Wednesday, November 29, 2023 Fireside chat: 8:00am ET A live webcast of the presentations will be available in the News and Events section of the Company’s website at www.inspiremd.com/en/events/. Replays...

Continue reading

Worksport Gears Up for Initial Alpha Release of its Pioneering COR Portable Energy Storage System

West Seneca, New York, Nov. 02, 2023 (GLOBE NEWSWIRE) — Worksport Ltd. (Nasdaq: WKSP; WKSPW) (“Worksport” or the “Company”) proudly announces it is preparing for an alpha release of its highly anticipated COR battery system. In anticipation of the system’s alpha release, the Company is streamlining its supply chain, marked by the strategic forging of partnership agreements with esteemed global suppliers. The Company expects this initial release of its COR battery system to serve as a preliminary user iteration prior to its anticipated mass-market release in North America, with future intentions of releasing the system in other key global markets. This invaluable phase aims to harness the feedback from a select group of test users to allow the Company to finetune the COR system, ensuring optimal performance, bug-free operation,...

Continue reading

Sensus Healthcare to Host Third Quarter 2023 Financial Results and Business Update Conference Call on Thursday, November 9, 2023

BOCA RATON, Fla, Nov. 02, 2023 (GLOBE NEWSWIRE) — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, November 9, 2023 at 4:30 p.m. Eastern time to discuss the financial results for the third quarter of 2023. In addition, management will provide a business update and a discussion on recent and upcoming milestones. Participants are encouraged to pre-register for the conference call using this link. Upon registration participants will receive a unique dial in number that will permit them to bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. Those without internet access or unable...

Continue reading

American Oncology Network Launches New Cancer Foundation

American Oncology Cares Foundation and fund provide non-medical financial assistance to adult cancer patients.American Oncology Network Introduces New Cancer FoundationFrom left to right: Todd Schonherz, AON’s chief executive officer; Carlos Arce-Lara, MD, medical oncologist at Cancer & Blood Specialists of Arizona; and Shelly Glenn, AON’s chief growth and relationship officer.FORT MYERS, Fla., Nov. 02, 2023 (GLOBE NEWSWIRE) — American Oncology Network (AON) (Nasdaq: AONC) announced today the launch of its cancer foundation, the American Oncology Cares Foundation. The Foundation will raise funds to provide essential non-medical financial assistance for adult cancer patients. Cancer is one of the most expensive diseases to treat. According to a National Cancer Institute study, over 70% of cancer patient...

Continue reading

ProPhase Labs to Host Third Quarter 2023 Financial Results Conference Call on Thursday, November 9, 2023 at 11:00 a.m. Eastern Time

GARDEN CITY, NY, Nov. 02, 2023 (GLOBE NEWSWIRE) — ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics, therapeutics and diagnostics company, will hold a conference call on Thursday, November 9, 2023, at 11:00 a.m. Eastern time to discuss its results for the third quarter ended September 30, 2023 and provide a business update. A press release detailing these results will be issued prior to the call. ProPhase Labs’ CEO and Chairman of the Board of Directors, Ted Karkus, will host the conference call, followed by a question-and-answer period. To access the call, please use the following information:Date: Thursday, November 9, 2023Time: 11:00 a.m. Eastern time, 8:00 a.m. Pacific time   Participants can register for the conference call by navigating to: https://dpregister.com/sreg/10184034/faeb9e53fc Please...

Continue reading

MIMEDX to Highlight Published Data at SAWC Fall

Company Will Sponsor Lunch Symposium on November 3, 2023 MARIETTA, Ga., Nov. 02, 2023 (GLOBE NEWSWIRE) — MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced it will sponsor an Innovation Theater lunch symposium at the Symposium on Advanced Wound Care (SAWC) Fall meeting taking place November 2-5 in Las Vegas, NV. In addition, the Company will participate in the conference’s exhibition at booth number 511. In the session, Drs. Mouawad, Tettelbach, and Wahab will review recent data examining the clinical and economic impacts of using skin substitutes in the treatment of Venous Leg Ulcers (“VLUs”) as well as published data evaluating the impact of adequate debridement in the treatment algorithm of chronic wounds and how it translates to clinical outcomes. These faculty presenters will also discuss their clinical...

Continue reading

Pacira BioSciences Reports Third Quarter 2023 Financial Results

— New ASA initiatives to advance education and innovation for the anesthesia community — — PDUFA action date for EXPAREL as a lower extremity nerve block on track for November 13, 2023 — — Conference call today at 8:30 a.m. ET — TAMPA, Fla., Nov. 02, 2023 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today reported financial results for the third quarter of 2023. Third Quarter 2023 Financial HighlightsTotal revenues of $163.9 million Net product sales of $128.7 million for EXPAREL, $28.8 million for ZILRETTA, and $5.3 million for iovera° Net income of $10.9 million, or $0.23 per share (basic and diluted) Adjusted EBITDA of $52.9 millionSee “Non-GAAP Financial Information”...

Continue reading

Textainer Group Holdings Limited Reports Third-Quarter 2023 Results and Declares Dividend

HAMILTON, Bermuda, Nov. 02, 2023 (GLOBE NEWSWIRE) — Textainer Group Holdings Limited (NYSE: TGH; JSE: TXT) (“Textainer”, “the Company”, “we” and “our”), one of the world’s largest lessors of intermodal containers, today reported financial results for the third-quarter ended September 30, 2023. Key Financial Information (in thousands except for per share and TEU amounts) and Business Highlights:    QTD      Q3 2023     Q2 2023     Q3 2022  Total lease rental income   $ 192,497     $ 192,163     $ 205,152  Gain on sale of owned fleet containers, net   $ 5,197     $ 7,703     $ 22,788  Income from operations   $ 92,165     $ 97,678     $ 123,292  Net income attributable to common shareholders   $ 44,677     $ 51,332     $ 76,400  Net income attributable to common shareholders    per diluted common share   $ 1.07     $ 1.20     $ 1.64  Adjusted...

Continue reading

Talkspace Announces Third Quarter 2023 Results

B2B payor revenue grew 132% year-over-year 3Q 2023 Operating expenses of $24.0 million, down 30% year-over-year Reduced Net Loss to $4.4 million and Adjusted EBITDA1 loss to $2.8 million, an improvement of 75% and 82% year-over-year, respectively NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) — Talkspace, Inc. (NASDAQ: TALK), today reported third quarter 2023 financial results.    Three Months   Nine MonthsPeriod Ended September 30, 2023 (Unaudited)   Results   Variance fromPrior Year %   Results   Variance fromPrior Year %(In thousands unless otherwise noted)                Number of B2B eligible lives at period end (in millions)   113   31%   113   31%Number of completed B2B sessions during the period   228.6   105%   600.8   102%Number of Consumer active members at period end   13.3   (26)%   13.3   (26)%                 Total...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.